The latest edition of Cornell's Health Policy Insight Panel asked leading scholars about proposed Marketplace policies Majorities agreed: 1. Converting ePTCs to HSA contributions would, on balance, worsen affordability (70%) 2. Requiring small premiums would cause avoidable coverage loss (75%)

Excited to share that I'll be in conversation with former Surgeon General Vivek Murthy @newyorker.com Festival on October 25! We'll be talking community and connection, A.I. and social media, political polarization and public health, and much more... Tickets at the link below!

Recently, Dhruv Khullar travelled to Harvard to witness a face-off between a new A.I. model named CaBot and an expert diagnostician. Both correctly solved a patient's case. What does this mean for the future of medicine?

loved this conversation between Joshua Rothman and @dhruvkhullar.bsky.social on how A.I. might change the medical profession: www.newyorker.com/newsletter/t...

“With the federal government in retreat, vaccine wars have shifted to the states.” @dhruvkhullar.bsky.social writes about how states are abiding by, enforcing, or fighting against Robert F. Kennedy, Jr.,’s vaccine-policy rollbacks.

A.I. is different from virtually every other diagnostic technology: its results change depending on what you ask of it. But, perhaps, “the capriciousness of A.I. could also be turned into an asset,” Dhruv Khullar writes. nyer.cm/uVKDtkj

How good is A.I. at making medical diagnoses? Good enough to help—and to hurt. For @newyorker.com, I spent months talking to patients, doctors, and researchers about how we can make the most of a powerful new technology and how we can minimize the side effects.

In this week's @newyorker.com, I write about what it's like to live with progeria—a disease that causes rapid, brutal aging—and the patients, advocates, and scientists who have brought us to the brink of a cure. www.newyorker.com/magazine/202...

Can A.I. find new uses for old drugs? Some scientists think that many lifesaving treatments are hiding in plain sight—if only we knew where to look. My new piece in @newyorker.com

"At a time when the country faces no shortage of health threats, the value of evidence and expertise is itself under attack. The anti-establishment has become the establishment, and its decisions will affect us all." — @dhruvkhullar.bsky.social www.newyorker.com/news/the-led...

In a new paper, we find that the percentage of Americans who believe the government should pay for health care has increased over time, with notable increases among younger adults, people with lower incomes, Independents, and Republicans:

I had a chance to sit down with the legendary Marion Nestle for this interview in @newyorker.com Radio Hour. We covered the history of nutrition, recent research on ultra-processed foods, and policy levers that could help bring about a healthier America.

In this week's @newyorker.com, I revisit "The Case of Anna H.," by Oliver Sacks. Sacks has come to feel like the practitioner of a lost art distinct from modern medicine. But he understood that the particularity of a case—its texture, its humanity, its narrative—could illuminate how the mind works

How many NIH supported "life-changing" studies have been or will be terminated? This one on the Diabetes Prevention Program Outcomes Study, by @dhruvkhullar.bsky.social @newyorker.com www.newyorker.com/news/the-led...

📌 CHPC faculty, Drs. Amy Bond, Dhruv Khullar, Will Schpero, Yasin Civelek and colleagues explore what constitutes the modal primary care practice for Medicare beneficiaries in their paper out now in JAMA Health Forum @wschpero.bsky.social @dhruvkhullar.bsky.social @yasincivelek.bsky.social

What constitutes the modal primary care practice? In service of ongoing work characterizing the outpatient delivery system, we tried to figure it out. New paper now at JAMA Health Forum, with @ambond.bsky.social and @dhruvkhullar.bsky.social et al. jamanetwork.com/journals/jam...

A thrill to join Don Berwick and Kedar Mate for this episode of Turn on the Lights! We discussed recent HHS cuts, corporatized medicine, ultra-processed food, the future of health care, and more...

I joined @cnn.com to discuss the worsening measles outbreak in Texas and elsewhere. Every death is a tragedy—and a preventable tragedy.

Our Cornell Health Policy Center @chpc-cornell.bsky.social has an all-star leadership team: @wschpero.bsky.social, @dhruvkhullar.bsky.social, @ambond.bsky.social Jeff Niederdeppe, Maria Fitzpatrick, Sean Nicholson, Emily Workman, Kayla Tormohlen

In a new @jama.com Viewpoint, we examine two under-appreciated elements of enrollment in the Medicare Advantage program: jamanetwork.com/journals/jam...

Enjoyed joining @amanpourcopbs.bsky.social for this wide-ranging conversation on ultra-processed foods, chronic disease, and the steps we can take toward healthier diets:

In @newyorker.com's 100-Year Anniversary Issue, I write about what space travel does to the human body—and the scientists trying to figure out how to keep people safe on a roundtrip journey to Mars...

"Calorie density, probably the feature of food that had the biggest impact on our ancestors’ survival, now seemed to be among the most responsible for making us overeat." Fascinating piece by @dhruvkhullar.bsky.social. www.newyorker.com/magazine/202...

In this week's @newyorker.com, I write about a paradigm shift in nutrition science. What, exactly, are ultra-processed foods—and what, exactly, are they doing to our bodies?

New in Annals of Internal Medicine, @dannagal.bsky.social and I discuss 3 fundamental needs that underlie people's beliefs — comprehension, control, community — and offer suggestions for how clinicians and health systems can guide patients toward evidence-based practices.

The skinny on ultra-processed foods www.newyorker.com/magazine/202... @newyorker.com by @dhruvkhullar.bsky.social

I had a chance to join CBS News and Major Garrett to discuss my recent @newyorker.com piece on the consequences of money in medicine. Is U.S. health care entering a "gilded age"?

My new piece @newyorker.com on the Gilded Age of Medicine, in which patients are often treated less as humans in need of care than consumers who generate profit.